Navigation Links
BioStorage Technologies Brings Together Industry Leaders for Global Sample Management Benchmarking Symposium
Date:9/23/2010

INDIANAPOLIS, Sept. 23 /PRNewswire/ -- The volume of biological samples generated during clinical research is rapidly increasing as the pharmaceutical and biotechnology industries shift their focus from traditional medicine to molecular-based therapeutics. The growing use of genomics and biomarkers in the discovery process has put an increasing emphasis on the value of sample integrity and the practices that life sciences companies employ to collect, store and distribute clinical trial samples.

With this in mind, BioStorage Technologies held its first annual Global Sample Management Benchmarking Symposium at the company's state-of-the-art biorepository facility in Griesheim, Germany on September 15, 2010. The consortium brought together industry thought leaders from the life sciences community to share perspectives on sample management trends, challenges and strategies for optimizing biorepository operations.

"We couldn't be more pleased with the outcome of the symposium," said Lori A. Ball, chief operating officer. "We set out to bring together a cross-section of industry experts who could give insightful perspectives on the various aspects of sample management, and based on the acclaim from the assortment of executives in attendance, we feel we have set a good foundation for future thought leadership forums."

Attendees included executives and operations personnel from pharmaceutical and biotechnology companies, global CROs, central laboratories and academia. They received real-world insights into the state of sample management and what the industry must do to keep pace with the advancements of technology in the drug development process.

The impressive speaker line up included:

  • Dr. Elizabeth Foot, Chief Scientific Officer, London Genetics, Ltd., "Growing Trends in the Retrospective Analysis of Clinical Trial Samples"
  • Jens Mattuschka, Director Clinical Logistics Services W
    '/>"/>

SOURCE BioStorage Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. BioStorage Technologies, Inc., Welcomes Catherine Michael as Global Head of Sample Management Operations
2. BioStorage Technologies, Inc., Appoints Jeff Goddard to Global Head of Sales
3. BioStorage Technologies Takes Lead Sponsorship Role of 2nd Annual IIR Biorepositories Conference
4. BioStorage Technologies, Inc. Promotes Lori Ball to Senior Vice President and Expands Role
5. BioStorage Technologies Partners with Susan G. Komen for the Cure(R) Tissue Bank at the IU Simon Cancer Center in Breast Cancer Research Initiative
6. RF Technologies® Names Mark Harwood New President
7. IntriMed Technologies Launched to Address Challenges Faced by Medical Device Manufacturers
8. BioSpecifics Technologies Corp. to Present at UBS Global Life Sciences Conference
9. NanoPass Technologies Ltd. and Elcam Medical Enter Into a Strategic Partnership
10. Energy technologies not enough to sufficiently reduce carbon emissions, NYUs Hoffert concludes
11. BioSpecifics Technologies Corp. to Present at Rodman & Renshaw 12th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... - BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today ... air emission abatement projects in North America ... for a municipality in the Southern USA ... that failed to meet the customer,s requirements. This demonstrates the value ... S. Webb , President and Chief Executive Officer.  ...
(Date:8/31/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/53wxp3/israel_biomedical ) has announced ... - Growth, Trends & Forecasts (2014-2020)" report to ... market is estimated at $0.19 billion by 2018 at ... The near future will bring biomedical sensors that ... These sensors can be set to trigger alerts when ...
(Date:8/31/2015)... 2015  US-Australian drug discovery company, Novogen Limited ... its comprehensive scientific review has identified high value ... of unmet patient need. Novogen is moving as ... prior to entering into Phase 1 clinical trials ... Chief Executive Officer, Iain Ross , said ...
(Date:8/31/2015)... (PRWEB) , ... August 31, 2015 , ... ... as a high priority in the drug development approval process. Thus, innovator companies ... This year, Regis Technologies, Inc., a Chicago-based CMO, has been hosting multiple educational ...
Breaking Biology Technology:Israel Biomedical Sensors Market 2015 - Growth, Trends & Forecasts to 2020 2Novogen Announces The Outcome Of A Comprehensive Science Review 2Novogen Announces The Outcome Of A Comprehensive Science Review 3Novogen Announces The Outcome Of A Comprehensive Science Review 4Novogen Announces The Outcome Of A Comprehensive Science Review 5Novogen Announces The Outcome Of A Comprehensive Science Review 6Regis Shares Expert Advice on Impurities in Drug Development 2Regis Shares Expert Advice on Impurities in Drug Development 3
... 4, 2010 -- Thin layers of oxide materials and their ... the first time by researchers at the Center for Nanophase ... Laboratory, providing new insight into the complicated link between their ... ability to see in color, or in 3-D," said the ...
... Aug. 4 Forte, LLC, today ... web-based probate database and estate recovery application that ... Finder OnDemand provides access to a proprietary database ... powerful matching algorithms that accurately match deceased accounts ...
... Aug. 4 New England Biolabs is ... Genome Sciences Center has selected New England Biolabs as ... construction reagents. NEBNext DNA Sample Prep Reagent Sets contain ... for sample preparation for next generation sequencing, as well ...
Cached Biology Technology:Unprecedented look at oxide interfaces reveals unexpected structures on atomic scale 2Forte Launches Probate Finder OnDemand™ 2Forte Launches Probate Finder OnDemand™ 3Canada's Michael Smith Genome Sciences Center Validates NEBNext™ DNA Sample Preparation Reagents From New England Biolabs for Use in Next Generation Sequencing 2Canada's Michael Smith Genome Sciences Center Validates NEBNext™ DNA Sample Preparation Reagents From New England Biolabs for Use in Next Generation Sequencing 3
(Date:8/20/2015)... The wearable technology market has traditionally ... healthy. However, wearable technology has the potential to ... improve diagnostic capabilities and therapeutic outcomes. Today, Leaf ... Technologies Conference 2015 , where Barrett Larson ... healthcare.    "Over the past decade, ...
(Date:8/18/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/9dmm6l/global_biometric ... "Global Biometric Authentication & Identification Market: Focus On ... 2015-2020" report to their offering. ... market is expected to grow at an estimated ... generate over $25 billion (approximately) by 2020 as ...
(Date:8/12/2015)... 2015  Synaptics Inc. (NASDAQ: SYNA ), ... announced that four of its fingerprint ID products, ... been named FIDO Certified™ by the Fast IDentity ... Synaptics, Natural ID™ fingerprint solutions are fully compliant ... standard and are interoperable among other products and ...
Breaking Biology News(10 mins):Leaf Healthcare Releases Video from Wearable Technology Conference on New Applications for Wearables in the Hospital Environment 2Leaf Healthcare Releases Video from Wearable Technology Conference on New Applications for Wearables in the Hospital Environment 3Global Biometric Authentication & Identification Market 2015: Focus On Modality, Motility & Application - Estimation & Forecasts to 2020 for the $25 Billion Industry 2Synaptics Announces FIDO Certification of Natural ID Fingerprint Solutions 2Synaptics Announces FIDO Certification of Natural ID Fingerprint Solutions 3
... and Edythe L. Broad Institute of Harvard and MIT ("the ... from the Boston-based Klarman Family Foundation to support a new ... This grant will allow the scientific community to ... health and disease, paving the way for major treatment breakthroughs. ...
... new system for delivering a drug to organ transplant patients, ... being developed by scientists at the University of Strathclyde in ... transplant operations and helps prevent the patient,s body rejecting the ... which the most serious problems are kidney and liver damage, ...
... 26, 2012   Reportlinker.com announces that a ... its catalogue: Biometrics Market ... TechNavio,s analysts forecast the ... a CAGR of 42.4 percent over the ...
Cached Biology News:Broad Institute awarded $32.5 million grant to launch new 'Cell Observatory' 2Broad Institute awarded $32.5 million grant to launch new 'Cell Observatory' 3System to deliver organ transplant drug -- without harmful side effects 2Biometrics Market in India 2010 - 2014 2
... Fragment, Exonuclease Minus, is a DNA-dependent DNA ... the 3´→5´ exonuclease activities present in intact ... is used for random primer labeling (3,4) ... Fragment, Exonuclease Minus, will leave a single-base ...
SMVT (N-14)...
...
... Dideoxycytidine is a cytidine analog that has ... activity. Immunogen: Chemical / Small ... The specificity of the ddC antiserum was determined ... ddC to moles of ddC analog at the ...
Biology Products: